Novo Nordisk launches bidding war with Pfizer for US obesity biotech Metsera
Denmark's Novo Nordisk (NOVOb.CO) launched a rival bid for U.S. obesity biotech firm Metsera (MTSR.O) on Thursday, hijacking an offer from Pfizer (PFE.N) as the drugmakers jostled for advantage in the...